PMID: 7514710Jan 1, 1994Paper

Constitutive mu opioid receptor activation as a regulatory mechanism underlying narcotic tolerance and dependence

Life Sciences
Z WangW Sadée

Abstract

Chronic administration of narcotic mu opioid agonists results in tolerance and dependence. We propose that agonist stimulation causes a gradual conversion of mu receptors to a constitutively active state (mu*) as a key step in tolerance and physical dependence. We provide evidence in support of the existence of mu* in human neuroblastoma cells, SH-SY5Y, and mu* upregulation during morphine treatment. Naloxone blocked mu* activity, acting as an antagonist with negative intrinsic activity which accounts for its high potency in eliciting withdrawal. In contrast, the mu selective antagonist CTAP did not affect mu* activity but inhibited naloxone's effect. The protein kinase inhibitor H7 was found to suppress mu* formation, suggesting that mu* is phosphorylated. In a model of acute morphine tolerance/dependence in mice, H7 prevented naloxone induced withdrawal jumping and reversed morphine (antinociceptive) tolerance. CTAP caused only mild withdrawal and attenuated naloxone induced withdrawal, as predicted for an antagonist without negative activity. These results support a role for constitutive mu receptor activation in narcotic tolerance and dependence, affording potential separation of acute and chronic narcotic effects.

References

Mar 1, 1976·The Journal of Pharmacy and Pharmacology·A Cowan
Aug 1, 1975·Proceedings of the National Academy of Sciences of the United States of America·S K SharmaM Nirenberg
Jul 2, 1992·Nature·T KutsuwadaM Arakawa
Feb 1, 1992·Brain : a Journal of Neurology·J G OjemannE Lettich
Jun 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·A R Gintzler, H Xu
Nov 15, 1990·Biochemical and Biophysical Research Communications·J M HerbertJ P Maffrand
Jan 1, 1990·Pharmacology, Biochemistry, and Behavior·D ParolaroM Parenti
Aug 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·L L WerlingB M Cox
Oct 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·T Costa, A Herz
Jan 1, 1974·Pharmacology·L GrumbachJ E Boston
Nov 1, 1969·Australasian Radiology·J M Reid
Feb 14, 1980·Nature·H O Collier
Apr 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·R A CrucianiM H Makman
Oct 14, 1993·Nature·R J Lefkowitz

❮ Previous
Next ❯

Citations

Apr 4, 2013·Naunyn-Schmiedeberg's Archives of Pharmacology·Pamela R TsurudaDavid T Beattie
Feb 8, 2005·Psychopharmacology·Andrew C Harris, Jonathan C Gewirtz
Nov 11, 2003·Life Sciences·Eva V VargaWilliam R Roeske
May 24, 2005·Pharmacology, Biochemistry, and Behavior·David A WhiteStephen G Holtzman
May 23, 1998·European Journal of Pharmacology·M A Bernstein, S P Welch
Mar 27, 2001·Pharmacology, Biochemistry, and Behavior·M R ZarrindastM Shafizadeh
Dec 14, 2002·Pharmacology, Biochemistry, and Behavior·Mohammad Reza ZarrindastHassan Ghoshouni
Dec 26, 2001·Brain Research. Brain Research Reviews·J G Liu, K J Anand
Apr 1, 1997·Journal of Neuroimmunology·E Z Tomei, F L Renaud
May 14, 2009·The Journal of Pharmacology and Experimental Therapeutics·Sunil SirohiByron C Yoburn
Jun 11, 2004·Annual Review of Biochemistry·Maria WaldhoerJennifer L Whistler
Jun 21, 2006·Journal of Addictive Diseases·Paolo MannelliElisabeth J Van Bockstaele
Jan 1, 1995·NIDA Research Monograph·G W Pasternak
Jun 7, 2000·The Biochemical Journal·N T BurfordW Sadée
Mar 29, 2013·Expert Opinion on Drug Safety·Mellar DavisPam Gamier
Jul 9, 2011·Pharmacology, Biochemistry, and Behavior·Dipesh M NavaniByron C Yoburn

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.